Raymond Despax

846 total citations
8 papers, 461 citations indexed

About

Raymond Despax is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Raymond Despax has authored 8 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Raymond Despax's work include Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Raymond Despax is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Raymond Despax collaborates with scholars based in France, Italy and Netherlands. Raymond Despax's co-authors include Jaap Verweij, I Hudson, Giorgio Bolis, G.J. Creemers, M. Gore, Simon Van Belle, G. Favalli, Ángel J. Lacave, W.W. ten Bokkel Huinink and Jean‐Paul Guastalla and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Breast.

In The Last Decade

Raymond Despax

7 papers receiving 440 citations

Peers

Raymond Despax
Comparison fields: 5 of 62
  • Oncology 237
  • Reproductive Medicine 220
  • Molecular Biology 162
  • Surgery 155
  • Obstetrics and Gynecology 84
Replace G.J. Creemers with:
G.J. Creemers Netherlands
W. P. McGuire United States
Ami Vaidya United States
Gloria Mittica Italy
Eleonora Zaccarelli Italy
Lyndsay Willmott United States
Salah T. Fayed Egypt
Karen Zempolich United States
Jenny Brändstedt Sweden
Jole Ventriglia Italy
G.J. Creemers Netherlands View profile →
Citations per field, relative to Raymond Despax
Raymond Despax · 1×
Citations per year, relative to Raymond Despax
Raymond Despax · 1×

Countries citing papers authored by Raymond Despax

Since Specialization
Citations

This map shows the geographic impact of Raymond Despax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Despax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Despax more than expected).

Fields of papers citing papers by Raymond Despax

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Despax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Despax. The network helps show where Raymond Despax may publish in the future.

Co-authorship network of co-authors of Raymond Despax

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Despax. A scholar is included among the top collaborators of Raymond Despax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Despax. Raymond Despax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 8
2 1
3 26
4 331
5
Choriocarcinoma and endocrine paraneoplastic syndromes.
1
6
A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP).
77
7 16
8
[Acute myelomonocytic leukemia with hyperleukocytosis. Symptomatic treatment with cytapheresis and plasma exchange].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026